Drug intelligence / Profile preview

NKL peptide

Development stage
Preclinical
Modality
Peptides
Administration
Subcutaneous, Intramuscular, Intravenous, Oral, Intranasal, Inhalation, Transdermal, Sublingual, Buccal, Rectal, Vaginal, Ophthalmic
01

Overview

NKL peptides are synthetic antimicrobial peptides derived from NK-lysin, a naturally occurring protein (human homolog is granulysin) found in cytotoxic T lymphocytes and natural killer cells. These peptides are cationic and amphipathic, primarily acting by disrupting bacterial plasma membranes and forming transmembrane pores, which leads to bacterial death. They can also induce genomic DNA degradation in bacteria. NKL peptides exhibit broad-spectrum activity, including antibacterial effects against various Gram-positive and Gram-negative bacteria, antiviral activity against viruses like Nodavirus and Rotavirus, and antiparasitic effects against parasites such as Eimeria sporozoites. Additionally, they demonstrate cytotoxic activity against cancer cells, inducing apoptosis, and possess immunomodulatory properties, influencing immune responses by upregulating chemokines and cytokines. NKL peptides are being investigated for therapeutic applications in both human and veterinary medicine, particularly in aquaculture for fish and poultry.

Other names
NK-lysinNklgranulysin
02

Targets

Neuraminidase

Beyond the preview

Go deeper on NKL peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NKL peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call